Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 12, 2013, Pages 7354-7361

  van den Bosch, Thierry ^a   Koopmans, Anna E ^a   Vaarwater, Jolanda ^a   van den Berg, Mike ^a   de Klein, Annelies ^a   Verdijk, Robert M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemokine receptors; SNP analyses; Survival analyses; Uveal melanoma

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CHROMOSOME 1; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME 8; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DNA ISOLATION; EPITHELIOID CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; NECROSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE MICROARRAY; UVEA MELANOMA;

CHEMOKINE RECEPTORS; SNP ANALYSES; SURVIVAL ANALYSES; UVEAL MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOKINE CXCL12; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, CCR7; RECEPTORS, CXCR4; SURVIVAL ANALYSIS; UVEAL NEOPLASMS;

EID: 84887328963     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12407     Document Type: Article

References (39)

1. van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract. 2010;2010:360136.
2. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118: 1881-1885.
3. Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989-998.
4. Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S, Kivelä T. A prognostic model and staging for metastatic uveal melanoma. Cancer. 2003;97:465-475.
5. Gill HS, Char DH. Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol. 2012;47:246-253.
6. Schaeuble K, Hauser MA, Rippl AV, et al. Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration. J Cell Sci. 2012;125:4463-4474.
7. Li P, Zhao Z-J, Liu F-Y, et al. The chemokine receptor 7 regulates cell adhesion and migration via 1 integrin in metastatic squamous cell carcinoma of the head and neck. Oncology Reports. 2010;24:989-995.
8. Wang J, Zhang X, Thomas SM, et al. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene. 2005;24:5897-5904.
9. Li J, Sun R, Tao K, Wang G. The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9. Dig Liv Dis. 2011;43:40-47.
10. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer. 2003;105:186-189.
11. Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric garcinoma. Cancer Res. 2002;62:2937-2941.
12. Li P, Liu F, Sun L, et al. Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3. Int J Mol Med. 2011;27:679-687.
13. Calpe E, Codony C, Baptista MJ, et al. ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation. Blood. 2011;118:4401-4410.
14. Wiley HE, Gonzalez EB, Maki W, Wu M-T, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst. 2001;93:1638-1643.
15. Kühnelt-Leddihn L, Müller H, Eisendle K, Zelger B, Weinlich G. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10? Arch Dermatol Res. 2012;304:185-193.
16. Dobner BC, Riechardt AI, Joussen AM, Englert S, Bechrakis NE. Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis. Acta Ophthalmologica. 2012;90:638-644.
17. Zhuo W, Jia L, Song N, et al. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis. Clin Cancer Res. 2012;18:5387-5398.
18. Scala S, Ieranò C, Ottaiano A, et al. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol Immunother. 2007;56:1589-1595.
19. Li H, Alizadeh H, Niederkorn JY. Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Invest Ophthalmol Vis Sci. 2008;49:636-643.
20. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol. 2007;292:C987-C995.
21. Vaarwater J, van den Bosch T, Mensink HW, et al. Multiplex ligation-dependent probe amplification equals fluorescence insitu hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Melanoma Res. 2012; 22:30-37.
22. Natali PG, Hamby CV, Felding-Habermann B, et al. Clinical significance of αvβ3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res. 1997;57:1554-1560.
23. Seftor RESE, Hendrix MJ. Molecular role(s) for integrins in human melanoma invasion. Cancer Metastasis Rev. 1999;18: 359-375.
24. Elshaw SR, Sisley K, Cross N, et al. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of α1β1, α4β1 and α6β1 integrins. Br J Ophthalmol. 2001;85:732-738.
25. Baker JKL, Elshaw SR, Mathewman GEL, et al. Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression. Melanoma Res. 2001;11:265-273.
26. Rubie COV, Kempf K, Wagner M, et al. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumor Biol. 2006;27:166-174.
27. Bonacchi A, Petrai I, Defranco RMS, et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology. 2003;125:1060-1076.
28. Rubie C, Frick VO, Wagner M, et al. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol. 2006;7:6627-6633.
29. Scholes AGM, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003;44:1008-1011.
30. Slettenaar VIF, Wilson JL. The chemokine network: a target in cancer biology? Adv Drug Deliv Rev. 2006;58:962-974.
31. Ramos EAS, Grochoski M, Braun-Prado K, et al. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer. PLoS ONE. 2011;6:e29461.
32. Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010;29:16.
33. Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29:1716-1722.
34. Franco RBG, Mascolo M, Loquercio G, et al. CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. Front Biosci (Elite Ed). 2010;1:13-21.
35. Scala S, Ottaiano A, Ascierto PA, et al. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res. 2005;11:1835-1841.
36. Kilic E, Naus NC, van Gils W, et al. Concurrent loss of chromosome Arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005;46:2253-2257.
37. Harbour JW, Onken MD, Roberson EDO, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410-1413.
38. Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917-921.
39. Bakalian S, Marshall J-C, Logan P, et al. Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin Cancer Res. 2008;14:951-956.